FTSE All-Share
|
5 322,73
|
7,15
|
0,13 %
|
Analysen zu FTSE All-Share-Werten
| 19.02.25 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 19.02.25 | HSBC Holdings Equal Weight | Barclays Capital | |
| 19.02.25 | National Grid Buy | Goldman Sachs Group Inc. | |
| 19.02.25 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 19.02.25 | HSBC Holdings Neutral | UBS AG | |
| 19.02.25 | HSBC Holdings Buy | Goldman Sachs Group Inc. | |
| 18.02.25 | Unilever Outperform | Bernstein Research | |
| 17.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 17.02.25 | BAT Buy | Deutsche Bank AG | |
| 17.02.25 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.02.25 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 17.02.25 | BAT Neutral | Goldman Sachs Group Inc. | |
| 14.02.25 | BAT Sector Perform | RBC Capital Markets | |
| 14.02.25 | Unilever Buy | Deutsche Bank AG | |
| 14.02.25 | Unilever Sell | UBS AG | |
| 13.02.25 | Unilever Underperform | RBC Capital Markets | |
| 13.02.25 | BAT Buy | UBS AG | |
| 13.02.25 | Unilever Sell | UBS AG | |
| 13.02.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 13.02.25 | Unilever Outperform | Bernstein Research | |
| 13.02.25 | BAT Neutral | Goldman Sachs Group Inc. | |
| 13.02.25 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 13.02.25 | BAT Sector Perform | RBC Capital Markets | |
| 13.02.25 | BAT Buy | UBS AG | |
| 13.02.25 | BAT Neutral | JP Morgan Chase & Co. | |
| 13.02.25 | Unilever Underperform | Jefferies & Company Inc. | |
| 13.02.25 | Rio Tinto Neutral | UBS AG | |
| 13.02.25 | AstraZeneca Buy | UBS AG | |
| 12.02.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 12.02.25 | National Grid Overweight | JP Morgan Chase & Co. | |
| 12.02.25 | BP Sector Perform | RBC Capital Markets | |
| 12.02.25 | BP Buy | UBS AG | |
| 12.02.25 | BP Buy | Goldman Sachs Group Inc. | |
| 11.02.25 | BP Verkaufen | DZ BANK | |
| 11.02.25 | BP Buy | Goldman Sachs Group Inc. | |
| 11.02.25 | BP Sector Perform | RBC Capital Markets | |
| 11.02.25 | BP Buy | Jefferies & Company Inc. | |
| 11.02.25 | BP Underweight | JP Morgan Chase & Co. | |
| 11.02.25 | BP Buy | UBS AG | |
| 11.02.25 | AstraZeneca Outperform | Bernstein Research |